Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K-001 vs Ganfuling in advanced hepatocellular carcinoma
CTR20132922Phase 2Completed
- Sponsor
- Beijing Huashi Tianfu Biopharmaceutical Technology
- Start
- Feb 2014
- Countries
- 1
01
Overview
A Phase 2 trial of K-001 in hepatocellular carcinoma (HCC), sponsored by Beijing Huashi Tianfu Biopharmaceutical Technology. Started Feb 2014; status: completed.
02
Drugs
K-001
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on CTR20132922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132922.